Growth Stalk Holdings 過去の業績
過去 基準チェック /06
Growth Stalk Holdings's earnings have been declining at an average annual rate of -28.6%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 144.2% per year.
主要情報
-28.6%
収益成長率
23.8%
EPS成長率
| Pharmaceuticals 業界の成長 | 6.0% |
| 収益成長率 | 144.2% |
| 株主資本利益率 | -81.1% |
| ネット・マージン | -53.3% |
| 前回の決算情報 | 31 Dec 2023 |
最近の業績更新
更新なし
Recent updates
更新なし
収支内訳
Growth Stalk Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Dec 23 | 1 | 0 | 1 | 0 |
| 31 Mar 23 | 0 | 0 | 1 | 0 |
| 31 Dec 22 | 0 | 0 | 1 | 0 |
| 30 Sep 22 | 0 | 0 | 0 | 0 |
| 30 Jun 22 | 0 | 0 | 0 | 0 |
| 31 Mar 22 | 0 | 0 | 0 | 0 |
| 31 Dec 21 | 0 | 0 | 0 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
質の高い収益: GSTK is currently unprofitable.
利益率の向上: GSTK is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: Insufficient data to determine if GSTK's year-on-year earnings growth rate was positive over the past 5 years.
成長の加速: Unable to compare GSTK's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: GSTK is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.4%).
株主資本利益率
高いROE: GSTK has a negative Return on Equity (-81.1%), as it is currently unprofitable.